Faculty profile

Jonathan Gubbay

ResearcherInstitute of Biomaterials and Biomedical EngineeringUniversity of Toronto

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.

Jonathan Gubbay

Researcher

Institute of Biomaterials and Biomedical Engineering

Health Sciences

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
7 publications in the last five years, latest in 2025.
Principal investigator on 1 research grant (1 CIHR), most recently in 2017.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

299

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Diagnostics Infectious Disease Nanotechnology Point Of Care

Latest papers

Disproportionate Rates of COVID-19 Among Black Canadian Communities: Lessons from a Cross-Sectional Study in the First Year of the Pandemic.
Journal of racial and ethnic health disparities · 2025
Population immunity to varicella in Canada: A Canadian Immunization Research Network (CIRN) study.
PloS one · 2024
Burden of Severe Illness Associated With Laboratory-Confirmed Influenza in Adults Aged 50-64 Years, 2010-2011 to 2016-2017.
Open forum infectious diseases · 2023

All 31 publications

Latest funding

COVID-19 Vaccine Responses among African Canadian Children with and without Sickle Cell Disease
CIHR · 2021 · Co-investigator
$482,223
COVID-19 Vaccine Responses among African Canadians: Sustainability of Immune Responses and Safety Profiles.
CIHR · 2021 · Co-investigator
$467,999
Influenza vaccines, statins, and laboratory-confirmed influenza outcomes in older adults: can vaccines and statins reduce the burden of influenza?
CIHR · 2018 · Co-investigator
$202,725

All 7 grants and awards

31 publications.

Disproportionate Rates of COVID-19 Among Black Canadian Communities: Lessons from a Cross-Sectional Study in the First Year of the Pandemic.

Allen UD, Barton M, Upton J, Bailey A, Campigotto A, Abdulnoor M, Julien JP, Gubbay J, Kissoon N, Litosh A, La Neve MR, Wong P, Allen A, Bailey R, Byrne W, Jagoowani R, Phillips C, Merreles-Pulcini M, Polack A, Prescod C, Siddiqi A, Summers A, Thompson K, Thompson S, James C, seroMARK Research Group

Journal of racial and ethnic health disparities2025

DOI: 10.1007/s40615-023-01903-z PMID: 38253978

Population immunity to varicella in Canada: A Canadian Immunization Research Network (CIRN) study.

Wright J, Crowcroft N, McLachlan E, Perez-Iratxeta C, Joh E, Osman S, Hatchette T, Deeks SL, Wilson SE, Hughes SL, Halperin SA, Buchan SA, Ward BJ, Gubbay J, Brisson M, Serhir B, Severini A, Bolotin S

PloS one2024

DOI: 10.1371/journal.pone.0309154 PMID: 39159217

Burden of Severe Illness Associated With Laboratory-Confirmed Influenza in Adults Aged 50-64 Years, 2010-2011 to 2016-2017.

Kim P, Coleman B, Kwong JC, Plevneshi A, Hassan K, Green K, McNeil SA, Armstrong I, Gold WL, Gubbay J, Katz K, Kuster SP, Lovinsky R, Matukas L, Ostrowska K, Richardson D, McGeer A

Open forum infectious diseases2023

DOI: 10.1093/ofid/ofac664 PMID: 36632417

Environmental Testing of Surfaces in the Room of a Patient With Mpox.

Muller MP, Mishra S, McGeer A, Patel S, Gubbay J, Hasso M, Chan AK, Kozak R, Leis JA, Tan DS

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America2023

DOI: 10.1093/cid/ciac654 PMID: 35982540

Estimating the Incidence of First RSV Hospitalization in Children Born in Ontario, Canada

Buchan SA, Chung H, To T, Daneman N, Guttmann A, Kwong JC, Murti M, Aryal G, Campigotto A, Chakraborty P

Journal of the Pediatric Infectious Diseases Society202331 citationsOpen Access

DOI: 10.1093/jpids/piad045 PMID: W4381308561

Detection of Large Genomic RNA via DNAzyme‐Mediated RNA Cleavage and Rolling Circle Amplification: SARS‐CoV‐2 as a Model

Gu J, Mathai A, Nurmi C, White D, Panesar G, Yamamura D, Balion C, Gubbay J, Mossman K, Capretta A

Chemistry - A European Journal202325 citations

DOI: 10.1002/chem.202300075

Population immunity to measles in Canada using Canadian Health Measures survey data - A Canadian Immunization Research Network (CIRN) study.

Osman S, Crowcroft N, McLachlan E, Hatchette T, Perez-Iratxeta C, Joh E, Wright J, Halperin SA, Deeks S, Wilson S, Buchan S, Ward B, Gubbay J, Brisson M, Serhir B, Severini A, Bolotin S

Vaccine2022

DOI: 10.1016/j.vaccine.2022.04.011 PMID: 35491342

Evaluation of commercial SARS-CoV-2 serological assays in Canadian public health laboratories.

Stein DR, Osiowy C, Gretchen A, Thorlacius L, Fudge D, Lang A, Sekirov I, Morshed M, Levett PN, Tran V, Kus JV, Gubbay J, Mohan V, Charlton C, Kanji JN, Tipples G, Serhir B, Therrien C, Roger M, Jiao L, Zahariadis G, Needle R, Gilbert L, Desnoyers G, Garceau R, Bouhtiauy I, Longtin J, El-Gabalawy N, Dibernardo A, Lindsay LR, Drebot M, Canadian Public Health Laboratory Network (CPHLN) Serology Task Force

Diagnostic microbiology and infectious disease2021

DOI: 10.1016/j.diagmicrobio.2021.115412 PMID: 34425450

Practical guidance for clinical laboratories for SARS-CoV-2 serology testing.

Charlton C, Kanji J, Tran V, Kus J, Gubbay J, Osiowy C, Robinson J, Sekirov I, Drebot M, Hatchette T, Stein D, El-Gabalawy N, Lang A, Jiao L, Levett P, Wood H, Therrien C, Lindsay LR, Morshed M, Forbes J, Dibernardo A

Canada communicable disease report = Releve des maladies transmissibles au Canada2021

DOI: 10.14745/ccdr.v47i04a01 PMID: 34035663

S-Gene Target Failure as a Marker of Variant B.1.1.7 Among SARS-CoV-2 Isolates in the Greater Toronto Area, December 2020 to March 2021

Brown KA, Gubbay J, Hopkins J, Patel S, Buchan SA, Daneman N, Goneau LW

Journal of the American Medical Association (JAMA)2021123 citations

DOI: 10.1001/jama.2021.5607

Something wrong or missing on this profile? Suggest a correction

Jonathan Gubbay

Research

Latest papers

Latest funding

Disproportionate Rates of COVID-19 Among Black Canadian Communities: Lessons from a Cross-Sectional Study in the First Year of the Pandemic.

Population immunity to varicella in Canada: A Canadian Immunization Research Network (CIRN) study.

Burden of Severe Illness Associated With Laboratory-Confirmed Influenza in Adults Aged 50-64 Years, 2010-2011 to 2016-2017.

Environmental Testing of Surfaces in the Room of a Patient With Mpox.

Estimating the Incidence of First RSV Hospitalization in Children Born in Ontario, Canada

Detection of Large Genomic RNA via DNAzyme‐Mediated RNA Cleavage and Rolling Circle Amplification: SARS‐CoV‐2 as a Model

Population immunity to measles in Canada using Canadian Health Measures survey data - A Canadian Immunization Research Network (CIRN) study.

Evaluation of commercial SARS-CoV-2 serological assays in Canadian public health laboratories.

Practical guidance for clinical laboratories for SARS-CoV-2 serology testing.

S-Gene Target Failure as a Marker of Variant B.1.1.7 Among SARS-CoV-2 Isolates in the Greater Toronto Area, December 2020 to March 2021

COVID-19 Vaccine Responses among African Canadian Children with and without Sickle Cell Disease

COVID-19 Vaccine Responses among African Canadians: Sustainability of Immune Responses and Safety Profiles.

Influenza vaccines, statins, and laboratory-confirmed influenza outcomes in older adults: can vaccines and statins reduce the burden of influenza?

Engineering DNAzyme-gold nanoparticle diagnostic device

Linking laboratory and administrative data to study influenza and influenza vaccine epidemiology

Severe influenza in infants, children and youths: Role of clinical and epidemiologic risk factors

Severe influenza in infants, children and youth: Role of clinical and epidemiologic risk factors

Frequent collaborators

Tony Mazzulli

Allison McGeer

Shelly Bolotin

Todd Hatchette

Samir Patel

Marc Brisson

Aaron Campigotto

Rachel Savage

Andrew Simor

Inna Sekirov

Sarah Wilson

Marek Smieja

James Wright

Samira Mubareka

Michelle Science

Deborah Yamamura

Mel Krajden

Nick Daneman

Mark Loeb

Gregory Tyrrell

Alexander Summers

Eleanor Pullenayegum

Irene Armstrong

Effie Gournis

Jessica Hopkins

Peter Wong

Michelle Murti

John Kuruvilla

Curtis Cooper

Derek Stein

Gaston De Serres

Fiona Smaill

Sam Ratnam

Philip Kim

Teresa To

Astrid Guttmann

Janet Raboud

Scott Halperin

Michel Roger

Brian Ward